InsidersTradesSigma
Track the Pharmaron Beijing Co., Ltd. share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Pharmaron Beijing Co., Ltd. has recorded 4 reports. Market capitalisation: €43.5bn. The latest transaction was disclosed on 6 May 2026 (Other). Among the most active insiders: Lou Xiaoqiang. All data is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharmaron Beijing Co., Ltd. Strong Buy (bullish), based on 12 analysts. Average price target: HK$30.74.
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,441 of 29,065 companies
50.3
score / 100
Value42
Quality58
FCF yld1.1%
Earn yld3.2%
EV/EBITDA17.9x
ROE10%
Gross mgn35%
Net mgn12%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 May 2026
Declarations4 total
4,450,000 sharesShareXHKGHKEX:DA20260506E00308
4,700,000 sharesShareXHKGHKEX:DA20260506E00307
11,000,000 sharesShareXHKGHKEX:DA20260430E00043
11,000,000 sharesShareXHKGHKEX:DA20260430E00044
4 of 4 declarations
关于 Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. 是一家为制药行业提供研发服务的公司。它提供从药物发现到生产的综合解决方案。